SCHEMBL12818812

SCHEMBL12818812

COc1ncc(-c2ccc3c(c2)N(S(=O)(=O)c2ccc4nc(C)oc4c2)CCO3)cn1

nearest known ligand 0.43

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ CYP2C9 P11712 1/20 0.43
▸ NPC1 O15118 1/20 0.41
▸ KMT2A Q03164 5/20 0.39
▸ MEN1 O00255 4/20 0.39
▸ MAPT P10636 3/20 0.39
▸ TP53 P04637 1/20 0.39
▸ CYP3A4 P08684 1/20 0.39
▸ CYP2D6 P10635 1/20 0.39
▸ PDE3B Q13370 4/20 0.35
▸ PDE3A Q14432 4/20 0.35
▸ KLK3 P07288 1/20 0.35
▸ POLB P06746 1/20 0.35
▸ PIK3CA P42336 1/20 0.35
▸ USP2 O75604 1/20 0.34
▸ GAA P10253 1/20 0.34
▸ PKM P14618 1/20 0.34
▸ ALDH1A1 P00352 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12818912 0.89 PIK3CA (0.42) CYP2C9NPC1KMT2AMEN1MAPT
SCHEMBL12818485 0.87 PDE3B (0.39) CYP2C9NPC1KMT2AMEN1MAPT
SCHEMBL12818721 0.87 CYP2C9 (0.40) CYP2C9NPC1KMT2AMEN1MAPT
SCHEMBL12818506 0.85 CYP2C9 (0.42) CYP2C9NPC1KMT2AMEN1MAPT
SCHEMBL12818620 0.84 LMNA (0.42) CYP2C9NPC1KMT2AMEN1MAPT
SCHEMBL12818304 0.82 PKM (0.43) CYP2C9NPC1KMT2AMEN1MAPT
SCHEMBL12818134 0.80 CYP2C9 (0.40) CYP2C9NPC1KMT2AMEN1MAPT
SCHEMBL12818063 0.79 NPC1 (0.42) CYP2C9NPC1KMT2AMEN1MAPT
SCHEMBL12818990 0.78 CYP2C9 (0.38) CYP2C9NPC1KMT2AMEN1MAPT
SCHEMBL12817618 0.75 MEN1 (0.41) CYP2C9NPC1KMT2AMEN1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012130306-A1 BICYCLIC 2,3-DIHYRDOBENZAZINE COMPOUNDS FOR USE IN THERAPY ELARA PHARMACEUTICALS GMBH (DE) 2012-10-04 — — WO claimed
WO-2012130306-A1 BICYCLIC 2,3-DIHYRDOBENZAZINE COMPOUNDS FOR USE IN THERAPY ELARA PHARMACEUTICALS GMBH (DE) 2012-10-04 — — WO disclosed
Send feedback